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Aim: To compare the peroperative blood loss and the postoperative systemic nflammatory eaction in patients receiving 
either a Vasculour I! Albumin pre-impregnated prosthesis (VA group, n = 32) or a preclotted Vasculour II prosthesis (V 
group, n -- 33) for elective surgery of the abdominal orta. 
Setting: University Hospital. 
Design: Prospective, randomised study. 
Methods: Peroperative blood loss was measured over two different periods: Phase I from the beginning of the operation to 
the completion ofthe proximal anastomosis, when blood loss cannot be related to the model of prosthesis implanted and 
phase II after the completion ofthe proximal anastomosis to the end of the operation. Postoperative blood loss was evaluated 
by the determination f the retroperitoneal drainage volume over a period of 2 days immediately following the operation. 
The presence ofperiprosthetic fluid was measured with echography atdays 4, 9, 30 and 60. The postoperative systemic 
inflammatory eaction was evaluated by measuring the sedimentation rate and the C reactive protein levels daily from day 
1 to day 9, and at days 14, 21, 28, 45, and 60, and by measuring the body temperature daily from day 1 to day 9. 
Results: No significant differences ofperoperative blood loss were observed. The same proportion of patients (35%) in both 
groups received homologous transfusion. The mean number of units of homologous blood transfused per patient was 
respectively 0.77 and 0.91 for the VA and the V group. The retroperitoneal drainage volume and the percentage of patients 
with periprosthetic fluid did not differ significantly. No significant differences in systemic postoperative inflammatory 
reaction were observed. 
Conclusion: There were no benefits in using albumin-impregnated prosthesis a  opposed to preclotted prosthesis in terms 
of peroperative and postoperative blood loss, or by looking at the incidence ofhomologous blood transfusion. However, the 
glutaraldehyde cross-linked albumin did not induce any systemic nflammatory eaction. 
Key Words: Blood vessel prosthesis; Polyester; Albumin-impregnated; Abdominal ortic surgery; Blood loss; Inflammatory 
reaction; Randomised controlled trial. 
Introduction 
Polyester vascular prostheses were designed with a 
porous textile structure in order to promote infiltration 
and anchorage by the surrounding tissue after implan- 
tation. 1"2 However, high porosity could be responsible 
for blood loss through the prosthetic wall after 
releasing the clamps. Preclotting of the prosthesis is 
usually with the patient's blood before systemic 
injection of heparin. An alternative procedure consists 
in impregnating and/or coating the prosthesis with a 
bioerodible matrix at the time of the manufacturing 
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process. This concept was first introduced in the early 
sixties, 3-6 and has been commercially available since 
the early eighties, using albumin, 7 gelatin8"90r colla- 
gen. 1° Impregnated prosthesis have become popular. 
The main reasons for their use are the reduction of 
intraoperative blood loss and consequently reduction 
of homologous transfusions, and the reduction of 
infection rate by limiting surgical handling during the 
preclotting stage. However, these theoretical advan- 
tages have never been firmly demonstrated. Moreover 
there may drawbacks uch as systemic inflammatory 
or immunological reactions related to the sealant. 
In a previous retrospective clinical study, 1~ we 
demonstrated good clinical results when an albumin- 
impregnated polyester prosthesis was used for the 
surgery of the abdominal aorta. The aim of this a 
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randomised clinical study was to compare an albu- 
min-impregnated vascular prosthesis with its pre- 
clotted skeleton in order to address two questions: 
1) Does the implantation of an impervious albumin- 
impregnated prosthesis reduce the amount of per- 
operative blood loss, and consequently the amount 
of homologous blood transfused, during elective 
aortoiliac surgery? 
2) Does the implantation of glutaraldehyde cross- 
linked albumin impregnated prosthesis cause a 
systemic inflammatory eaction? 
Materials and Methods 
Patients 
This study was conducted from February 1992 to April 
1993 in 65 patients. The criteria for inclusion of 
patients in the study was reconstructive surgery for 
abdominal aortic aneurysm (AAA) or aortobiiliac 
occlusive disease (AIOD) with an aortoaortic, aortobii- 
liac or aortobifemoral graft. Criteria for exclusion 
were: reoperation after previous reconstructive sur- 
gery of the abdominal aorta, associated renal superior 
mesenteric artery, or popliteal revascularisation, emer- 
gency surger)~ known immunological or allergic 
disease, or coagulopathy. Oral informed consent was 
obtained from each patient. The patients were rando- 
mised at the time of the operation to receive ither a 
preclotted DeBakey Vasculour II prosthesis (Bard 
USCI, Billerica, MA, U.S.A.) or a De Bakey Vasculour 
II Albumin (human albumin impregnated) prosthesis, 
using a random table. 
Preoperative biological evaluation included deter- 
mination of hemoglobin level, red blood cell, leuko- 
cyte, and platelet counts, sedimentation rate (SR), and 
C-reactive-protein (CRP). A prothrombotic state which 
could be responsible for early postoperative graft 
thrombosis was ruled out by evaluating the S protein. 
C protein and antithrombin III levels. 
Surgery 
The operations were conducted via a transperitoneal 
approach. Preclotting of the non-impregnated prosthe- 
ses was performed using 30-40 ml of non-heparinised 
aortic blood, following a two-step method as pre- 
viously described. 12Before arterial clamping, systemic 
anticoagulation was performed by injection of heparin 
(1.5mg/kg). The prostheses were implanted using 
polypropylene monofilament 4/0 running suture for 
aortic or iliac anastomoses and 6/0 running suture for 
femoral anastomoses. After completion of the anasto- 
moses and release of the clamps, heparin was reversed 
by protamine sulphate. The prosthesis was then 
covered by the aortic wall of the aneurysm or the 
retroperitoneal tissues. Redon suction drains (Char- 
riere 9) were placed along the prosthesis, and were 
taken out at the second postoperative day. Antibiotic 
prophylaxis was given as systemic intravenous injec- 
tion of 1.5 g of cefamandol atthe time of the operation) 
followed by four injections of 0.750 g during the first 
postoperative day. 
An intraoperative autotransfusion system (Cell 
Saver 4, Haemonetics, Braintree, MA, U.S.A.) was 
systematically used. Blood collected in the reservoir 
was washed and centrifuged only when the volume 
exceeded 500 ml. Washed blood cells were then rein- 
fused in the patient during or after the operation. 
Criteria for per and postoperative homologous trans- 
fusion were haemoglobin levels lower than 8 g/100 ml 
or haematocrit fractions lower than 25%. These thresh- 
olds were increased respectively to 10g/100ml and 
30% when patients uffered significant coronary dis- 
ease demonstrated at the preoperative coronarog- 
raphy performed in case of clinical angina or signs of 
ischaemia or myocardial infarction at the electro- 
cardiogram, and poor haemodynamic tolerance. 
Uneventful postoperative hospitalisation was 9 
days. The patients were discharged with coumadin 
anticoagulant therapy for a 6 week period. Perioper- 
ative events within the first month after operation 
were recorded. We evaluated mortality, morbidity and 
prosthetic thrombosis and infection. Delayed compli- 
cations were recorded over 2 months. 
Blood loss 
Blood lost during the operation was continuously 
collected by the suction tip. The use of sponges was 
limited to a minimum, and blood collected in sponges 
was gently squeezed and aspirated by the suction tip. 
In order to distinguish between prosthesis-related and 
unrelated blood loss, the collected volume was eval- 
uated over two different phases of the operation: 
Phase I extended from the abdominal wall incision 
to the completion of the proximal anastomosis, imme- 
diately before releasing the clamps. This phase 
included the blood lost during the exposure and the 
control of the vessel segments for anastomoses, and 
the blood leaking from the clamped vessel and/or 
from the lumbar arteries. 
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Phase II extended from the release of the proximal 
clamps to the completion of the operation. This phase 
included the blood lost at the level of the anastomoses 
and through the prosthetic wall after clamp release, 
and when applicable, the blood taken for the preclot- 
ting of the non-impregnated prostheses. 
Total blood loss was defined as the sum of phase I and 
phase II blood loss. Differences in blood loss attributa- 
ble to differences between preclotted and impregnated 
prostheses occur in phase II and not in phase I. 
The 2-day postoperative retroperitoneal volume 
drainage was considered an indirect sign of blood loss 
and recorded. Delayed periprosthetic blood loss was 
estimated by echography at days 4, 9, 30, and 60. The 
echographies were performed using a Duplex colour 
scan (Ultramark 8, Advanced Technology Laborato- 
ries, Seattle, WA, U.S.A.), by an examiner blinded to 
the type of prosthesis. The presence of periprosthetic 
fluid was scored as moderate or large. The number of 
units of homologous red cells transfused uring and 
after the operation were noted. 
Systemic inflammatory eaction 
Systemic inflammatory reaction was evaluated 
according to three criteria: 
The first was body temperature which was recorded 
four times daily during the first 2 postoperative days, 
and then twice daily for the following 7 days. The 
highest value of each day was noted. The two other 
criteria used were sedimentation rate and C reactive 
protein levels which were measured aily for the first 
9 postoperative days, and then at days 14, 21, 45, and 
60. 
Haematological parameters 
Red blood cell, leukocyte, and platelet counts, as well 
as haemoglobin and fibrinogen levels were measured 
at days 2, 4, 6, and 9 after the operation. 
Statistical analysis 
Student -test and non parametric mean comparison 
test in the case of non-normal distribution or non 
equal variance of the variables, were performed to 
analyse the continuous variables. Chi-square test was 
performed for discontinuous variables. A level of 
significance of 0.05 was chosen and expressed as p for 
the Student -test, and z for the non-parametric test. 
The results were given as mean + S.D. The statistical 
analysis was performed with Statgraphics oftware 
(vers. 5.00, 1991, STSC Inc.) 
Results 
At randomisation, the patients were included in the 
Vasculour II Albumin group (VA group) (n = 32), or 
the Vasculour II group (V group) (n = 33). These 
groups were not statistically different in terms of risk 
factors, indication for surgery and type of prosthesis 
implanted (straight vs. bifurcated prostheses)(Table 
!). 
The mean postoperative duration of the hospital- 
isation for the Vasculour II Albumin group was 
11.0 + 12.0 days (range; 7-30 days). There was no 
postoperative d ath. Morbidity consisted of one emer- 
gency reoperation for massive bleeding related to the 
leakage of the proximal anastomosis 2h after the 
implantation of an aortobiiliac prosthesis for AAA, 
one delirium tremens, one reoperation at the seventh 
postoperative day for a subcutaneous groin haema- 
toma, and one in situ venous femoropopliteal bypass 
performed on the eighth postoperative day for critical 
ischaemia. No thrombosis or infection of the graft 
occured. One patient died 45 days after surgery. The 
death was related to cerebral haemorrage secondary to 
anticoagulant therapy. No thrombosis or infection of 
the graft occurred. 
The mean postoperative duration of hospitalisation 
for the Vasculour II group was 9.9 + 4.3 days (range: 
7-25 days). There was no postoperative death. Mor- 
bidity consisted of one respiratory insufficiency with 
prolonged intubation and respiratory assistance, one 
Table 1. Patients characteristics at randomisation 
Vasculour II Vasculour II 
Albumin group group 
(n=32) (n=33) 
Age 67.8 _+ 8.7 66.4 + 11.7 
Sex 31 men/1 woman 31 men/2 women 
Indication for 
implantation 24 AAA/8 AIOD 25 AAA/8 AIOD 
Prosthesis 12 straight/ 17 straight/ 
20 bifurcated 16 bifurcated 
Tobacco 10 13 
Diabete 7 1 
Hypertension 18 21 
Dyslipidemia 21 22 
Carotid isease 4 5 
Coronary disease 12 14 
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urinary tract infection, two delayed cutaneous healing 
at the groin, two pneumonias, one ascitic decom- 
pensation, and one paraplegia following the surgery 
for AAA. No thrombosis or infection of the graft 
occured. No death, and no prosthetic thrombosis or 
infection of the graft occured. 
Blood loss 
After releasing the clamps the albumin-impregnated 
prostheses were found to be blood tight. Blood 
leakage through the preclotted wall of the Vasculour II
prostheses was limited and easily stopped by com- 
pression with sponges. No prolonged blood leakage 
was noted. Surgical handling was found to be similar 
for both prostheses. The blood loss in each phase for 
VA and V groups is presented in Fig. 1. No significant 
difference in blood loss was observed between each 
group and between procedures for AAA and for 
AIOD in each group (Fig. 2). Phase I: Blood loss was 
471.9 + 396.6 ml for the VA group and 
463.3 + 468.7 ml for V group. Phase II: Blood loss was 
629.2 + 675.3 ml for the VA group and 
655.9 + 616.3ml for the V group. Total preoperative 
blood loss: Blood loss was 1101.1 + 971.6ml for VA 
group and 1119.2 + 797.1ml for V group. 
The postoperative drainage volume values of two 
patients were excluded from the study. One patient in 
the VA group had massive postoperative bleeding 
because of the leaking of the proximal anastomosis. 
The second patient was in the V group and had 
postoperative ascitic decompensation with a drainage 
volume of ascitic liquid larger than 2000 ml. Excluding 
these two patients, the mean postoperative drainage 
volume was 530.7 + 262.4ml for the VA group and 
452.6 + 162.9 ml for the V group (NS). The percentage 
of patients with periprosthetic fluids detected by 
echography at days 4, 9, 30, and 60 were not 
significantly different between the two groups. Peri- 
prosthetic fluids collections were mainly moderate, 
and large in two cases (1 case per group). 34.4% of the 
preclotted prosthesis recipients had homologous 
transfusion as compared to 36.4% for the albumin- 
impregnated prostheses recipients. The difference was 
not significant. Mean units of homologous red cells 
transfused were 0.72 and 0.91 respectively (Table 2). 
Systemic inflammatory reaction 
Mean body temperature and peaks of temperature 
higher than 38.5°C were not significantly different 
between both groups (Fig. 3, Table 3). Sedimentation 
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Fig. 1. Scattergram showing blood loss in 32 procedures with Vasculour II Albumin prostheses compared with blood loss in 33 procedures 
with preclotted Vasculour II prostheses during phase I, phase II and the overall operation. (*) mean value; (O) value for each patient. 
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Fig. 2. Blood loss in procedures for AAA and AIOD in VA and V groups. ([:3) AAA, VA group; (~) AIOD, VA group; (ll) AAA, V group; 
(~) AIOD, V group. 
Table 2. Homologous red cells units transfused (mean + S.D.) 
Intraoperative Postoperative Overall operation 
transfusions transfusions transfusions 
V group 0.24+0.75 0.66+1.38 0.91+1.51 
VA group 0.34_+0.90 0.37_+0.98 0.72+1.22 
rates were similar for both groups, increasing to reach 
a plateau by day 3, with values near 50mm. This 
plateau lasted until day 14 after which time it 
gradually decreased back to values of 20 mm by day 
60. CRP levels were similar in both groups. CRP 
increased and peaked at day 3 post-surgery with 
values of 170rag/1 for the V group and 140mg/1 for 
the VA group. Preoperative values were re-established 
after day 21 post-surgery (Fig. 4). 
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Fig. 3. Postoperative body temperature in procedures with albumin-impregnated and preclotted prostheses. (ll) VA group; (C)) V 
group. 
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Table 3. Patients with postoperative body temperature peaks 
higher than 38.5°C 
v group VA group 
0 < day < 5 11 7 
4 < day < 10 1 0 
Haematological parameters 
No significant difference in haemoglobin levels were 
observed. Preoperative values were between 13 and 
14g/100ml. They decreased at the second post- 
operative day to near 10 g/100 ml and remained at this 
level for at least 7 more days. Leukocyte counts 
demonstrated fluctuations with time with higher 
values for the V group than for the VA group. 
Significant differences were noted at days 0 (z < 0.05) 
and 6 (z < 0.01). Leukocyte counts increased 2 days 
after surgery and returned to preoperative l vels by 9 
days after surgery. No specific reaction could be noted 
by differential counting in all patients. No significant 
differences related to platelet count were observed 
between the VA and the V group. The mean preopera- 
tive was 250 000/mm B. The minimal level was 
attained at day 2, and gradually increased to reach 
values between 350 000 and 400 000/ram 3 by day 9. 
Post-surgery fibrinogen levels increased in both 
groups to peak by day 4 and only slightly decreased 
over the subsequent 5 days. Fibrinogen level was 
significantly higher at day 6 for the V group than for 
the VA group (z < 0.05). 
Discussion 
Since the introduction of polyester vascular prosthe- 
ses, many improvements have been made to give 
them long term mechanical stability and optimal 
tissue encapsulation. The impregnation of the porous 
textile structure by a bioerodible matrix was first 
proposed as a way of keeping the wall impervious at 
the time of the implantation. Different techniques 
have been used to preclot prostheses for more than 
twenty years. 12A3 
Studies on the effect of impregnated polyester 
vascular prostheses on blood loss during aortic sur- 
gery have already been performed. The first studies 
were retrospective or prospective, but were not rando- 
mised) 4--17 They concluded that the use of such 
prosthesis reduced intraoperative blood loss and 
consequently the amount of homologous blood trans- 
fusions. Three previous randomised studies on the 
effect of impregnation of a polyester prosthesis on 
intraoperative blood loss have been published. 18-2° 
Harris et al. 18 did not demonstrate any differences in 
intraoperative blood loss when the prosthesis 
implanted for AIOD surgery was collagen-impreg- 
nated (950.3 + 567.5 ml) or preclotted 
(933.3 + 567.5 ml). On the other hand, De Mol van 
Otterlo et al. 19 demonstrated a significant overall 
difference in intraoperative blood loss between their 
collagen-impregnated (2425 ml) and preclotted 
(1907 ml) prosthesis recipients groups. They measured 
the intraoperative blood loss during three periods of 
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Fig. 4. Postoperative C reactive protein in procedures with albumin-impregnated nd preclotted prostheses. (#: z < 0.05). (m) VA groups; 
(0) V group. 
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the operation in order to differentiate between pros- 
thesis and non-prosthesis related blood loss. During 
their phase III, which characterised blood loss through 
the interstices of the prosthesis, no significant differ- 
ence was observed. Becquemin et al. 2° also failed to 
demonstrate any difference in intraoperative blood 
loss with the implantation of either an impregnated or
a preclotted prosthesis. 
In our randomised stud3~ the operative procedure 
was divided in two distinct phases in order to 
differentiate between prosthesis-related and non-pros- 
thesis-related intraoperative blood loss. In our hands, 
the use of albumin-impregnated prosthesis did not 
significantly reduce intraoperative blood loss. Dis- 
tribution of blood loss values during each phase and 
during the overall operation demonstrated a high 
variability in both groups. This high variability indi- 
cated that intraoperative blood loss is mainly related 
to factors other than the prosthesis uch as surgical 
difficulties. 
The 2 day postoperative periprosthetic drainage, 
which was considered an indirect estimation of 
delayed blood leakage through the wall of the 
prosthesis, showed no significant difference. The 
evaluation of the presence of periprosthetic fluid over 
2 months after the implantation of the prostheses was 
undertaken on the basis that blood oozing through the 
prosthetic wall could occur at the time of the fibrino- 
lytic reaction in the case of preclotted prostheses, or 
during bioresorbtion of the cross-linked albumin of 
the impregnated prostheses. There was no significant 
difference between the proportion of patients with 
periprosthetic fluids in each group. 
On the basis of SR and CRP, we failed to demon- 
strate any difference in systemic inflammatory reac- 
tion between the two prostheses. The Vasculour II 
Albumin prosthesis is impregnated with glutaralde- 
hyde cross-linked human albumin which could avoid 
immunological reactions. However, previous experi- 
mental studies also found good biocompatibility of 
this prosthesis in mice 21 and rats. 22 Previous clinical 
studies have described the effect of implanting pros- 
theses impregnated with different proteaneceous sea- 
lants on systemic inflammatory eactions. Vohra et al. 23 
measured the CRP and alpha-l-acid-protein levels 
following the implantation of either a gelatin-impreg- 
nated or a preclotted polyester prosthesis. This work 
suggested that the impregnation ofthe prosthesis with 
formaldehyde cross-linked gelatin did not exacerbate 
the postoperative inflammatory response. In a pro- 
spective randomised stud3~ the Canadian Multicenter 
Hemashield Study Group 24 concluded that bovine 
collagen, when used to impregnate the Hemashield 
prosthesis, can potentially stimulate an immunologic 
reaction in humans. However, this reaction was 
considered small and not clinically significant. Norg- 
ren et a lY  demonstrated no difference in the systemic 
inflammatory reaction following implantation of 
either a collagen-impregnated or a preclotted prosthe- 
sis. However, since four of the 11 patients who 
received a collagen impregnated prosthesis had a 
significantly increased titre of anticollagen antibodies, 
they concluded that the collagen used for the impreg- 
nation of the Hemashield prosthesis was antigenic 
despite the formaldehyde crosslinking. In our study, 
we chose to examine the CRP levels to evaluate the 
early acute inflammatory reaction. 26'27 SR was con- 
sidered as a different index of inflammation since it 
peaks later than CRP. Since the surgical trauma was 
similar in both groups, differences between them 
would be related to the implantation of the cross- 
linked albumin of the Vasculour II Albumin prosthe- 
sis. However, no significant differences in acute phase 
protein response to the different grafts was 
observed. 
In conclusion, the use of an albumin-impregnated 
prosthesis for the reconstruction of the abdominal 
aorta is safe since no increased inflammatory eaction 
was observed when compared to a preclotted prosthe- 
sis. However, the use of such a prosthesis failed to 
reduce the intraoperative blood loss and consequently 
the amount of homologous blood transfused. The 
albumin-impregnated prosthesis is more convenient 
when a blood-tight prosthesis is necessar3~ as for 
heparinised patients or for ruptured abdominal aneu- 
rysms or emergency abdominal aortic surgery. 
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